Turn Therapeutics TTRX
NASDAQ TTRX
$10.15 -0.32 (-3.06%)
At close: Oct 21, 2026 · 4:00 PM EDT

Turn Therapeutics (TTRX) Retained Earnings (2024 - 2026)

Updated

Turn Therapeutics (TTRX) reported Retained Earnings of -$29.21 million for Q2 2026.

Analysis

Turn Therapeutics (TTRX) Retained Earnings (2024 - 2026) Analysis & Trends

At the end of FY2025, Turn Therapeutics posted Retained Earnings of -$22.39 million.

  • By year, Retained Earnings came in at -$19.2 million in FY2024.
  • Per Business Quant data, the three quarters before Q2 2026 came in at -$23.4 million (Q1 2026), -$22.39 million (Q4 2025) and -$22.67 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 31.89 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 171.67 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -17.33 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 63.27 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 12.59 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -22.28 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 2.20 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 112.09 Bn
10 Turn Therapeutics 303.99 Mn 277.10 Mn - -29.21 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -29.21 Mn
Mar 31, 2026 -23.40 Mn
Dec 31, 2025 -22.39 Mn
Sep 30, 2025 -22.67 Mn
Dec 31, 2024 -19.20 Mn
API Access

Turn Therapeutics Retained Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=retained-earnings&ticker=TTRX&period=max&api_key=YOUR_API_KEY